Injective price prediction: Will $3.92 support hold as INJ drops 7.22%?
Injective (INJ) is trading at $4.21, down 7.22% on the day. The asset sits below its key short- and medium-term moving averages but remains above longer-term trend levels.
Highlights
- Injective (INJ/USD) remains under persistent short- and medium-term selling pressure, trading below key moving averages on the hourly chart.
- Momentum indicators predominantly signal a bearish outlook, though short-term exhaustion is present, and intraday volatility is elevated.
- The price is expected to range between $3.92 and $4.5 over the next 1–3 days, with a 68% probability of further downside.
Negative momentum confirmed as oscillators signal short-term exhaustion
On the hourly chart, INJ is trading below the MA-20 at $4.25 and MA-50 at $4.43, while still holding above the long-term MA-200 at $4.16. Resistance is defined by the Ichimoku Kijun level at $4.34. The Moving Average Convergence Divergence (MACD) signals a strong sell bias, confirmed by the Average Directional Index (ADX). The Relative Strength Index (RSI) is at 40.99, also indicating a sell signal, while the Stochastic RSI is in an overbought zone, pointing to potential short-term exhaustion. The Commodity Channel Index (CCI) is neutral, with Bull/Bear Power (BBP) suggesting buyers are attempting to stabilize price intraday. The Awesome Oscillator remains neutral, and intraday volatility has increased as prices trade in the middle of today’s range, with some divergences among oscillators hinting at short-term exhaustion even as overall signals skew negative.
Sideways trading expected as volatility and downside risk persist
For the next one to three trading days, INJ is expected to fluctuate within a range of $3.92 to $4.5. There is a 32% probability of an upward move and a 68% probability of a downward move during this interval. The baseline expectation is for the asset to trend sideways inside this volatility band; a break above $4.34 would open the way for further gains, while a drop below $3.92 could trigger continued bearish momentum to lower support levels.
Earlier, analysts noted that Injective faced persistent downside momentum despite recent network upgrades intended to improve utility and developer access. The current setup reinforces this bearish bias, with traders advised to monitor $3.92 as a critical support that could define the next leg lower should selling pressure intensify.
Latest Injective News
- Forex
- Crypto